Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.

The present study investigates the prognostic value of immunohistochemically detected cathepsin D expression in endometrial adenocarcinoma. Patients with surgically treated endometrial adenocarcinoma FIGO stages I-III and consecutive irradiation therapy were included in the study. When we performed...

Full description

Bibliographic Details
Main Authors: Lösch, A., Kohlberger, P., Gitsch, G., Kaider, A., Breitenecker, G., Kainz, C.
Format: Online
Language:English
Published: Nature Publishing Group 1996
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074555/
id pubmed-2074555
recordtype oai_dc
spelling pubmed-20745552009-09-10 Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Lösch, A. Kohlberger, P. Gitsch, G. Kaider, A. Breitenecker, G. Kainz, C. Research Article The present study investigates the prognostic value of immunohistochemically detected cathepsin D expression in endometrial adenocarcinoma. Patients with surgically treated endometrial adenocarcinoma FIGO stages I-III and consecutive irradiation therapy were included in the study. When we performed immunohistochemistry to detect cathepsin D in 115 tissue specimens 35 cases showed a positive reaction. In the univariate analysis cathepsin D expression showed significant prognostic value for overall survival (P-value = 0.007). In the multivariate analysis with established prognostic parameters (stage, grade) we found an independent prognostic value for cathepsin D (P-value = 0.002, relative risk = 3.8, 95% confidence interval 1.4 - 10.0). Immunohistochemical detection of cathepsin D could aid in predicting prognosis and planning therapy for patients with endometrial adenocarcinoma. Nature Publishing Group 1996-06 /pmc/articles/PMC2074555/ /pubmed/8664123 Text en
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Lösch, A.
Kohlberger, P.
Gitsch, G.
Kaider, A.
Breitenecker, G.
Kainz, C.
spellingShingle Lösch, A.
Kohlberger, P.
Gitsch, G.
Kaider, A.
Breitenecker, G.
Kainz, C.
Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
author_facet Lösch, A.
Kohlberger, P.
Gitsch, G.
Kaider, A.
Breitenecker, G.
Kainz, C.
author_sort Lösch, A.
title Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
title_short Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
title_full Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
title_fullStr Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
title_full_unstemmed Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
title_sort lysosomal protease cathepsin d is a prognostic marker in endometrial cancer.
description The present study investigates the prognostic value of immunohistochemically detected cathepsin D expression in endometrial adenocarcinoma. Patients with surgically treated endometrial adenocarcinoma FIGO stages I-III and consecutive irradiation therapy were included in the study. When we performed immunohistochemistry to detect cathepsin D in 115 tissue specimens 35 cases showed a positive reaction. In the univariate analysis cathepsin D expression showed significant prognostic value for overall survival (P-value = 0.007). In the multivariate analysis with established prognostic parameters (stage, grade) we found an independent prognostic value for cathepsin D (P-value = 0.002, relative risk = 3.8, 95% confidence interval 1.4 - 10.0). Immunohistochemical detection of cathepsin D could aid in predicting prognosis and planning therapy for patients with endometrial adenocarcinoma.
publisher Nature Publishing Group
publishDate 1996
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074555/
_version_ 1611407771623751680